The third issuance of corporate bonds issued by International Investment Bank (IIB) on the Romanian capital market starts trading on the main market of the Bucharest Stock Exchange (BVB).

The issue is structured in two tranches, both with 3 years maturity: one in Romanian currency is worth RON 300 million and pays an interest rate of ROBOR 3M + 1.5 percent and one in the foreign currency is EUR 60 million with an interest rate of 1.593 percent per annum.

“Without any exaggeration, the issue could be described as a historical occasion for both IIB and for Romania. The value of the issue for Romania is related to the fact that the IIB has become the first issuer on the BVB to place bonds denominated in EUR. Thus, the Bank is successfully achieving one of its strategic goals, to provide assistance for the development of the national stock markets of its member states in line with its mission,” said Nikolai Kosov, chairman of the IIB Board.

“It is a major achievement. We are talking about two offerings of bonds issued by the same entity, in RON and EUR, at the same time, using the Romanian capital market infrastructure, and for the first time in Romania traded and settled in EUR. We are convinced that through the BVB Group’s implementation of the trading and settlement rules and practices used in European mature markets we contribute significantly to increasing the trust and attractiveness of our market for foreign investors,” said Lucian Anghel, BVB president.

The issuance was intermediated by BT Capital Partners and Banca Comerciala Romana.

” Collaboration with IIB for the issuance of corporate bonds is already a tradition that we want to continue. We are also glad that we can help the Romanian financial environment by financing the local businesses,” said Daniela Secara, deputy general manager of BT Capital Partners.

Law firm PeliFilip assisted the International Investment Bank on the issuance.

The post Third issuance of International Investment Bank’s bonds starts trading on BVB appeared first on Business Review.